Someone been nibbling at ZIVOW of late.
Interesting .... dunno if meaningful or not but haven't been expecting to see much action on that given the exercise price is $33 now. Of course a deal with global animal pharma could run those sharply upward and offer high leverage ...... assuming stock price launches. Cheap option really with just under 2 years remaining on it.
ZIVO the stock ..... frankly surprised it has not bled. It's basically flat for a couple months now hanging around $8 save the occasional drop/rise due to wide spreads. As we've discussed there's basically little to no float on this.
Currently a bidder for 2600 shares at $7.60 which is more volume than what's been trading for entire days of late. That area seems to be getting solid support still.
I'm still sitting tight on swing.
I want to see update on algae production.
I want to see update or any indication whether there is more than 1 global animal pharma involved with the coccidiosis candidate.
I want to see indication of MONEY needs as I'm sure that cash is running low again. Ideally animal pharma getting involved would like to see part of deal include purchase of shares from ZIVO for funding .... and OWNERSHIP ...... meaning fully invested in the process AND door open to acquisition.
I would also like to see some other tests done with the algae as an ingredient against cholesterol, sports recovery, etc ...... Simple shit ... not a ton of money. They have GRAS designation ..... no excuses to be able to make some claims on some easy stuff.
Amigo Mike
Market Data 
Markets 
